Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health
Open accessThe DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
The fact that the bacteria in the human gastrointestinal (GI) tract play a symbiotic role was noted as early as 1885, well before we began to manage microbial infections using antibiotics. However, even with the first antimicrobial compounds used in humans, the sulfa drugs, microbes were recognized to be critically involved in the biotransformation of these therapeutics. Thus, the roles played by the microbiota in physiology and in the management of human health have long been appreciated. Detailed examinations of GI symbiotic bacteria that started in the early 2000s and the first phases of the Human Microbiome Project that were completed in 2012 have ushered in an exciting period of granularity with respect to the ecology, genetics, and chemistry of the mammalian-microbial axes of communication. Here we review aspects of the biochemical pathways at play between commensal GI bacteria and several mammalian systems, including both local-epithelia and nonlocal responses impacting inflammation, immunology, metabolism, and neurobiology. Finally, we discuss how the microbial biotransformation of therapeutic compounds, such as anticancer or nonsteroidal anti-inflammatory drugs, can be modulated to reduce toxicity and potentially improve therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The resulting SN-38 in the gut lumen exhibits toxicity towards intestinal epithelial cells and is thought to exacerbate the diarrhea found in up to 80% of CRC patients50, 51.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“Microbial β-glucuronidases can then liberate the glucuronide, allowing reabsorption of the aglycone into enterocytes. NSAIDs can be further metabolized into reactive metabolites by these gut epithelial cells, which causes mitochondrial and ER stress, compromising mucosal integrity and promoting inflammation51, 54.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“Microbial aging is a well-recognized phenomenon in mammals that directly relates to microbial metabolic diversity (29, 30).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“Faecalibacterium prausnitziia member of the normal human microbiota, has been associated with extension of the period of remission in patients with Crohn’s disease (77).”
BackgroundInduction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677 · cited 1×
“, indoles) that undergo host metabolism (sulfation, in this case) that could be detrimental for those with poor kidney function; such patients might experience increased levels of circulating toxic indoxyl sulfate (35).”
BackgroundCommensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Round, J. L., & Mazmanian, S. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909122107 · Cited by 2,233 · cited 1×
“In a few cases, the effector molecules of specific microbiota members have been identified, the most prominent example being polysaccharide A, which is produced by human commensal Bacteroides fragilis and induces IL-10 expression from regulatory Foxp3+ T cells (81).”
Background
Research works printed but not linked: 15
- Escherich T, 1885, Fortschr. Med., 3, 447
- Bachrach WH, 1988, Am. J. Gastroenterol., 83, 487
- Svartz N, 1988, Am. J. Gastroenterol., 83, 497
- Wostmann BS, 1983, Lab. Anim. Sci., 33, 46
- Delaloye J, 2013, Curr. Vasc. Pharmacol., 11, 123
- Arnold RJ, 2005, J. Support. Oncol., 3, 227
- Gupta E, 1994, Cancer Res., 54, 3723
- Mathijssen RH, 2001, Clin. Cancer Res., 7, 2182
- Hryniuk W, 1988, Important Adv. Oncol., 1988, 121
- Kehrer DF, 2001, Clin. Cancer Res., 7, 1136
- Mathijssen RH, 2001, Clin. Cancer Res., 7, 2182
- Fortun PJ, 2007, Curr. Opin. Gastroenterol., 23, 134
- Ju C, 1998, Drug Metab. Dispos., 26, 676
- Kent TH, 1969, Am. J. Pathol., 54, 237
- Fukumoto K, 2011, Int. J. Mol. Med., 27, 353
Cited by
Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Kayama, H., Okumura, R., & Takeda, K. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070119-115104 · Cited by 747
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
Microbiome-wide association studies link dynamic microbial consortia to disease
Gilbert, J. A., Quinn, R. A., Debelius, J., Xu, Z. Z., Morton, J., Garg, N., Jansson, J. K., Dorrestein, P. C., & Knight, R. (2016) · Nature · doi:10.1038/nature18850 · Cited by 718
Mucosal Ecological Network of Epithelium and Immune Cells for Gut Homeostasis and Tissue Healing
Kurashima, Y., & Kiyono, H. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052424 · Cited by 329
An atlas of β-glucuronidases in the human intestinal microbiome
Pollet, R. M., D'Agostino, E. H., Walton, W. G., Xu, Y., Little, M. S., Biernat, K. A., Pellock, S. J., Patterson, L. M., Creekmore, B. C., Isenberg, H. N., et al. (2017) · Structure · doi:10.1016/j.str.2017.05.003 · Cited by 289
“These effects have been alleviated in mice using bacterial GUS-targeted inhibitors (LoGuidice et al., 2012; Mani et al., 2014; Roberts et al., 2013; Saitta et al., 2014; Wallace et al., 2010, 2015).”
BackgroundSelf-citation
Metadata
- Authors
- Mani, S., Boelsterli, U. A., & Redinbo, M. R.
- Affiliations
- Albert Einstein College of Medicine (US)
- University of Connecticut (US)
- University of North Carolina at Chapel Hill (US)
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2014-01-06
- Volume
- 54
- Issue
- 1
- Pages
- 559-580
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- PMC
- PMC3947301
- OpenAlex
- W2116943058
- Cited by
- 48
- References
- 160
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 3
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA161879, CA 127231, R01CA161879, R01CA127231, CA98468, R01CA098468)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, commensal bacteria, human gut microbiome, microbial transformation, drug metabolism, drug toxicity, inflammation, metabolism, neurobiology, anticancer agents, nonsteroidal anti-inflammatory drugs, Human Microbiome Project, sulfonamides
- MeSH terms
- Irinotecan, Animals, Anti-Inflammatory Agents, Camptothecin, Disease Models, Animal, Enteritis, Eosinophilia, Gastritis, Glucuronidase, Humans, Lipopolysaccharides, Mammals, Gastrointestinal Tract, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health. https://app.cochat.ai/papers/10.1146/annurev-pharmtox-011613-140007
- The paper
- Mani, S., Boelsterli, U. A., & Redinbo, M. R. (2014). Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev-pharmtox-011613-140007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.